A01K2207/30 - CPC Classification Index

#1

20260131022

2026-05-14

GENE INTRODUCTION METHOD, GENE THERAPY METHOD, AND TISSUE REGENERATION METHOD

#2

20260091096

2026-04-02

MEASURING THE PROGRESS OF CARDIAC XENOGRAFT IMMUNE REJECTION

#3

20240206438

2024-06-27

SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF

#4

20230309521

2023-10-05

NOVEL METHOD FOR PREPARING ANIMAL MODEL OF CEREBROVASCULAR DISEASE AND METHOD FOR PRODUCING ANIMAL HAVING SMALL INDIVIDUAL DIFFERENCE IN SUSCEPTIBILITY TO CEREBROVASCULAR DISEASE ONSET BY USING ANIMAL MODEL FOR CEREBROVASCULAR DISEASE PREPARED THEREBY

#5

20230165901

2023-06-01

TREATMENT OF EXCESSIVE NEOVASCULARIZATION

#6

20220062393

2022-03-03

METHODS AND MATERIALS FOR REDUCING CARDIAC XENOGRAFT REJECTION

#7

20210228518

2021-07-29

COMPOSITIONS AND METHODS FOR TREATING REFRACTORY SEIZURES

#8

20210189349

2021-06-24

Esophageal tissue and/or organoid compositions and methods of making same

#9

20200190511

2020-06-18

MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF

#10

20200080081

2020-03-12

A METHOD FOR REGULATING THE FUNCTION OF A HEART CELL, RELATED NUCLEOTIDES AND COMPOUNDS

#11

20200053989

2020-02-20

Method for creating an animal model having traumatic optical nerve injury

#12

20190373863

2019-12-12

Animal wound model and methods of use

#13

20190309264

2019-10-10

Three Dimensional Bioprinted Tumor Models for Drug Testing

#14

20190125830

2019-05-02

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#15

20190086421

2019-03-21

Method for producing animal model of preterm birth and animal model of preterm birth produced by the method

#16

20180369286

2018-12-27

TREATMENT OF EXCESSIVE NEOVASCULARIZATION

#17

20180289841

2018-10-11

Preclinical model of neonatal necrotizing enterocolitis

#18

20180163204

2018-06-14

Micro-RNA family that modulates extracellular matrix genes and uses thereof

#19

20180042967

2018-02-15

Method for reducing the inflammatory activity of a stem cell transplant and use thereof

#20

20170368142

2017-12-28

Methods of treating cognitive impairment

#21

20170368139

2017-12-28

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#22

20170360906

2017-12-21

B4GALNT2 knock out pig

#23

20170339930

2017-11-30

METHOD OF REGULATING LIFESPAN USING TRANSGENIC CAENORHABDITIS ELEGANS

#24

20170333173

2017-11-23

Organ for transplantation and organ structure

#25

20170281579

2017-10-05

Methods for rescuing phenobarbital-resistance of seizures by ANA-12 or ANA-12 in combination with CLP290

#26

20170266255

2017-09-21

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain

#27

20170223937

2017-08-10

Knockout mouse, method for screening substance for suppressing mesial temporal lobe epilepsy, and method for selecting technique for suppressing mesial temporal lobe epilepsy

#28

20170132952

2017-05-11

Unilateral spinal cord compression

#29

20170128529

2017-05-11

CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION

#30

20160228468

2016-08-11

Method for reducing the inflammatory activity of a stem cell transplant and use thereof

#31

20160145609

2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#32

20160145608

2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#33

20160145607

2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#34

20160069868

2016-03-10

Methods of identifying compounds for the treatment of fibrosis by using S1PR5

#35

20150359207

2015-12-17

ANIMAL MODEL FOR EVALUATING PERFORMANCE OF HEMOSTATIC AGENT FOR INDUCING HEMORRHAGE IN COMMON CAROTID ARTERY OR SUPERIOR SAGITTAL SINUS, AND USE THEREOF

#36

20150265678

2015-09-24

Methods of treating cognitive impairment

#37

20150237837

2015-08-27

Non-Human Model for Wound Healing

#38

20140256795

2014-09-11

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#39

20140041065

2014-02-06

Rodent model of central neuropathic pain caused by dorsal root entry zone avulsion at T13

#40

20130261169

2013-10-03

Micro-RNA family that modulates fibrosis and uses thereof

#41

20130259908

2013-10-03

Micro-RNA family that modulates fibrosis and uses thereof

#42

20130230520

2013-09-05

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain

#43

20130195891

2013-08-01

Micro-RNA family that modulates fibrosis and uses thereof

#44

20130111614

2013-05-02

Implantation of a cardiac xenograft from a B4GALNT2KO and GTKO transgenic pig to reduce immunogenicity

#45

20130058871

2013-03-07

METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY

#46

20130053328

2013-02-28

Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway

#47

20120322096

2012-12-20

Animal stroke model

#48

20120208753

2012-08-16

Composition and Method for the Treatment or Prevention of Spinal Disorders III

#49

20120136044

2012-05-31

Compositions And Methods Of Inhibiting NADPH Oxidase Expression

#50

20120110683

2012-05-03

NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME

#51

20120066780

2012-03-15

Humanized NSG mouse, method of producing the same and use thereof

#52

20110311473

2011-12-22

Methods of treating cognitive impairment

#53

20110237514

2011-09-29

PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN

#54

20110229412

2011-09-22

ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND MEHTODS OF MAKING AND USING THE SAME

#55

20110183912

2011-07-28

AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR

#56

20110144182

2011-06-16

TREATMENT OF SURGICAL ADHESIONS

#57

20110008415

2011-01-13

NOVEL LIPOPHILIC COMPOSITIONS AND USES THEREOF

#58

20100316624

2010-12-16

TREATMENT OF FIBROSES AND LIVER DISORDERS

#59

20100285073

2010-11-11

Micro-RNA family that modulates fibrosis and uses thereof

#60

20100273854

2010-10-28

COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION

#61

20100249210

2010-09-30

METHODS AND COMPOSITIONS RELATED TO DLK-1 AND THE P38 MAPK PATHWAY IN NERVE REGENERATION

#62

20100226878

2010-09-09

Methods of inhibiting photoreceptor apoptosis

#63

20100111910

2010-05-06

Treatment of excessive neovascularization

#64

20100040551

2010-02-18

Rodent model of central neuropathic pain

#65

20100034746

2010-02-11

ANIMAL MODEL, SYSTEM, AND METHOD FOR SCREENING COMPOUNDS FOR ANTITHROMBOTIC AND/OR THROMBOLYTIC ACTIVITY

#66

20090317334

2009-12-24

OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS

#67

20090257955

2009-10-15

Model of experimentally induced chronic pain and uses thereof

#68

20090208513

2009-08-20

Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions